Bronchoalveolar lavage in diagnosis of ventilator-associated pneumonia in patients with burns.
Ventilator-associated pneumonia (VAP) remains a major cause of morbidity and mortality for patients with burns. In nonburn populations, bronchoalveolar lavage (BAL) excludes other pathology such as systemic inflammatory response syndrome. We hypothesized that BAL would decrease our false-positive VAP rate. All ventilated patients with burn injury who were admitted to our institution from July 2000 through June 2003 were included. After June 2001, BAL was used to make the diagnosis of VAP, with > or =10(4) organisms considered a positive result. Fifty patients met criteria for VAP, 21 in the pre-BAL period and 29 in the BAL period. Six patients (21%) in the BAL group had quantitative cultures <10(4) and were not treated. The outcomes for these patients were not different than those treated for VAP. There were no differences in age, TBSA size, antibiotic use, or ventilator days for the pre-BAL or BAL groups, although the pneumonia rate was lower for the BAL time period. The use of BAL eliminated the unnecessary antibiotic treatment of 21% of patients in the BAL time period and was associated with a lower rate of VAP.
Wahl
Wendy L
WL
University of Michigan Health System, 1500 East Medical Center Drive, Ann Arbor, MI 48109-0033, USA.
Ahrns
Karla S
KS
Brandt
Mary-Margaret
MM
Rowe
Stephen A
SA
Hemmila
Mark R
MR
Arbabi
Saman
S
D000293:Adolescent; D000328:Adult; D018893:Bronchoalveolar Lavage; D002056:Burns / Q000150:complications*; D002648:Child; D003937:Diagnosis, Differential; D005189:False Positive Reactions; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D011014:Pneumonia / Q000175:diagnosis* / Q000209:etiology*; D012121:Respiration, Artificial / Q000009:adverse effects*; D012680:Sensitivity and Specificity